Radiopharmacy in Saxony

Radiopharmacy is developing into a key technology in nuclear medicine cancer treatment. Saxony's ecosystem, particularly in the Dresden region, is ideally positioned for this.

Übersichtskarte Network Contact

Highly automated production of radiopharmaceuticals

Video "Radiopharmacy in Saxony"

In Dresden in particular, the field of radiopharmacy boasts a combination of stakeholders and expertise that is unique in Germany, spanning the entire value chain all the way to patients at Dresden University Hospital. Among other things, this is where nuclear medicine is being advanced through innovation and new avenues are being opened in the fight against cancer.

Privacy Policy.

When you play this video, information about your YouTube usage will be transmitted to the operator of the video platform in the USA and, if need be, such information may be stored. In addition, such external content as, for example, videos will be loaded and stored in your browser.

International market leaders and innovation drivers

A powerful network of companies and research institutions with a focus on radiopharmaceuticals has been established in Saxony. The growth nucleus was the former GDR core research center, today's HZDR, which met the demand for radio-pharmaceutical preparations even before reunification. It develops new substances for therapy and diagnostics as well as software algorithms for imaging with positron emission tomography (PET) and is working on equipping innovative immunotherapeutics with additional radioactive emitters.

Map of Radiopharmacy Facilities in Saxony

In Dresden in particular, the field of radiopharmacy boasts a combination of stakeholders and expertise that is unique in Germany, spanning the entire value chain all the way to patients at Dresden University Hospital. Here, among other things, nuclear medicine is being advanced through innovation, opening up new avenues in the fight against cancer.

Map of Radiopharmacy Facilities in Saxony (pdf, 2 MB)

nukliD® - Radiopharmacy Cluster

nukliD^® is a dynamic network in Saxony that specializes in radiopharmacy and offers a combination of expertise in this field that is unique in Germany. The network drives innovation in nuclear medicine and opens up new perspectives for cancer treatment.

Through close collaboration among the network’s partners, new approaches in nuclear medicine are emerging that improve the precision and effectiveness of cancer treatment. In addition, the network advocates for better framework conditions through political activities and lobbying to promote and accelerate progress in cancer research and treatment.

nukliD®